We further revealed that patients with IL-22Rhigh breast cancers displayed poorer survival rates compared to those with IL-22Rlow tumors (Figure 5) and that the IL-22R level exhibited a positive relationship with S1PR1 expression (Figure 1). This evidence concerns the gene IL22RA1 and breast carcinoma.